Partnership Xnovo: ZEISS signed strategic partnership agreement with Xnovo

JENA/Germany, K GE/Denmark, 17.10.2017.

The ZEISS Microscopy business group announced today that it has signed an exclusive strategic partnership agreement with Denmark-based Xnovo Technology ApS, a company that develops innovative software-based 3D X-ray imaging and analysis solutions. The two companies have already been working together over the past two years. This strategic partnership is targeting to further advance and expand the laboratory-based diffraction contrast tomography technique, commercialized as LabDCT, on ZEISS Xradia 520 Versa.

LabDCT was introduced to the market in 2015. The module non-destructively obtains 3D crystallographic information from polycrystalline samples. It enables a handshake between theoretical and practical worlds for predictive materials design. Combining grain orientation information with microstructural features such as cracks, porosity, and inclusions opens new possibilities for characterizing damage, deformation and growth phenomena in 3D materials science. This technique has previously only been available at synchrotron imaging facilities and can now be used in the laboratory.

The development of new materials needed in frontiering fields such as metals for additive manufacturing, alloys for bioengineering, or the high-strength-to-weight materials required by aerospace and automotive industries, requires the use of an expanding set of new research techniques.

Erik Mejdal Lauridsen, CEO and founder of Xnovo, a spin-out of the Technical University of Denmark, says, "We felt we could really accelerate the field of materials science by commercializing our discoveries. Through our partnership with ZEISS, our aspirations are finally becoming a reality."

Lourens Steger, Head of the product center X-ray microscopy at ZEISS, noted, "At ZEISS, we work diligently to understand the job our customer needs to do and invest in innovation to ensure their success. We look forward to working with Xnovo to develop important new analytical capabilities for our 3D X-ray microscopes."

Sinha Vybhav

Carl Zeiss Microscopy GmbH

Phone: +49 3641 64 3949

Fax:

vybhav.sinha@zeiss.com

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. The ZEISS Group develops, produces and distributes measuring technology, microscopes, medical technology, eyeglass lenses, camera and cinema lenses, binoculars and semiconductor manufacturing equipment. With its solutions, the company constantly advances the world of optics and helps shape technological progress. ZEISS is divided up into the four segments Research & Quality Technology, Medical Technology, Vision Care/Consumer Products and Semiconductor Manufacturing Technology. The ZEISS Group is represented in more than 40 countries and has over 50 sales and service locations, more than 30 manufacturing sites and about 25 research and development centers around the globe. In fiscal year 2015/16 the company generated revenue approximating 4.9 billion with over 25,000 employees. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. Carl Zeiss AG is the strategic management holding company that manages the ZEISS Group. The company is wholly owned by the Carl Zeiss Stiftung (Carl Zeiss Foundation).

Further information at www.zeiss.com

Microscopy

The Microscopy business group is the worlds only one-stop manufacturer of light, electron, X-ray and ion microscope systems. The portfolio compromises solutions and services for the life sciences and materials research as well as for industry, education and clinical practice. The business group is headquartered in Jena. Additional production and development sites are located in Oberkochen, G ttingen and Munich, as well as in Cambridge in the UK, and in Peabody, MA and Pleasanton, CA in the USA. The business group is allocated to the Research & Quality Technology segment. Around 6,100 employees work for the segment, generating revenue totaling 1.5 billion in fiscal year 2015/16.

About Xnovo Technology ApS

Xnovo Technology ApS, funded in December 2012, is the commercial result of more than 15 years of synchrotron and diffraction imaging research at the Technical University of Denmark. It specializes in the development of innovative 3D X-ray imaging solutions with emphasis on 3D crystallographic imaging. Xnovo strives to deliver novel, high-performing and user-friendly imaging tools to strengthen clients business and research by providing innovative, state-of-the-art characterization capabilities, without compromising usability and productivity.

Number: 0093-2017-ENG MI

Number of Words: 297

Number of Characters: 2138

LINK:	http://applications.zeiss.com/C1256A770030BCE0/WebViewTopNewsAllE/2F03...
	See more stories from zeiss

Most recent headlines